Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.

Bell BP, Damon IK, Jernigan DB, Kenyon TA, Nichol ST, O'Connor JP, Tappero JW.

MMWR Suppl. 2016 Jul 8;65(3):4-11. doi: 10.15585/mmwr.su6503a2. Review.

PMID:
27389903
2.

Early Identification and Prevention of the Spread of Ebola - United States.

Van Beneden CA, Pietz H, Kirkcaldy RD, Koonin LM, Uyeki TM, Oster AM, Levy DA, Glover M, Arduino MJ, Merlin TL, Kuhar DT, Kosmos C, Bell BP.

MMWR Suppl. 2016 Jul 8;65(3):75-84. doi: 10.15585/mmwr.su6503a11.

PMID:
27386933
3.

Preventing Zika Virus Infections in Pregnant Women: An Urgent Public Health Priority.

Bell BP, Boyle CA, Petersen LR.

Am J Public Health. 2016 Apr;106(4):589-90. doi: 10.2105/AJPH.2016.303124. No abstract available.

4.

Ebola 2014--new challenges, new global response and responsibility.

Frieden TR, Damon I, Bell BP, Kenyon T, Nichol S.

N Engl J Med. 2014 Sep 25;371(13):1177-80. doi: 10.1056/NEJMp1409903. Epub 2014 Aug 20. No abstract available.

5.

Challenges of infectious diseases in the USA.

Khabbaz RF, Moseley RR, Steiner RJ, Levitt AM, Bell BP.

Lancet. 2014 Jul 5;384(9937):53-63. doi: 10.1016/S0140-6736(14)60890-4. Epub 2014 Jul 1. Review.

PMID:
24996590
6.

Responding to the outbreak of invasive fungal infections: the value of public health to Americans.

Bell BP, Khabbaz RF.

JAMA. 2013 Mar 6;309(9):883-4. doi: 10.1001/jama.2013.526. No abstract available.

PMID:
23364868
7.

Socio-demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009-2010 influenza season.

Santibanez TA, Singleton JA, Santibanez SS, Wortley P, Bell BP.

Influenza Other Respir Viruses. 2013 May;7(3):383-92. doi: 10.1111/j.1750-2659.2012.00374.x. Epub 2012 May 9.

8.

Seroprevalence and correlates of hepatitis a among HIV-negative American men who have sex with men.

Bialek SR, Barry V, Bell BP, Valleroy LA, Behel S, Mackellar DA, Secura G, Thiede H, McFarland W, Ford WL, Bingham TA, Shehan DA, Celentano DD.

Sex Health. 2011 Sep;8(3):343-8. doi: 10.1071/SH10162.

PMID:
21851774
9.

Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey.

Klevens RM, Kruszon-Moran D, Wasley A, Gallagher K, McQuillan GM, Kuhnert W, Teshale EH, Drobeniuc J, Bell BP.

Public Health Rep. 2011 Jul-Aug;126(4):522-32.

10.

Impella assisted transradial coronary intervention in patients with acute coronary syndromes and cardiogenic shock: case series.

Bell BP, Iqtidar AF, Pyne CT.

Catheter Cardiovasc Interv. 2011 Nov 15;78(6):880-5. doi: 10.1002/ccd.23104. Epub 2011 Jun 6.

PMID:
21523889
11.

The science behind preparing and responding to pandemic influenza: the lessons and limits of science.

Schuchat A, Bell BP, Redd SC.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S8-12. doi: 10.1093/cid/ciq007. Review.

PMID:
21342904
12.

Incidence and transmission patterns of acute hepatitis C in the United States, 1982-2006.

Williams IT, Bell BP, Kuhnert W, Alter MJ.

Arch Intern Med. 2011 Feb 14;171(3):242-8. doi: 10.1001/archinternmed.2010.511.

PMID:
21325115
13.

Preventing complications from 2009 influenza A (H1N1) in persons with underlying lung diseases: a formidable challenge for 2010 Year of the Lung.

Castro KG, Bell BP, Schuchat A.

Int J Tuberc Lung Dis. 2010 Feb;14(2):127-9. No abstract available.

PMID:
20074400
14.

Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.

Bialek SR, Helgenberger L, Fischer GE, Bower WA, Konelios M, Chaine JP, Armstrong G, Williams IT, Bell BP.

Pediatr Infect Dis J. 2010 Jan;29(1):18-22. doi: 10.1097/INF.0b013e3181b20e93.

PMID:
19841605
15.

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose.

McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, Bulkow L, Fiore AE, Bell BP, Hennessy TW.

J Infect Dis. 2009 Nov 1;200(9):1390-6. doi: 10.1086/606119.

PMID:
19785526
16.

Complementary and alternative medicine use in chronic liver disease patients.

Ferrucci LM, Bell BP, Dhotre KB, Manos MM, Terrault NA, Zaman A, Murphy RC, Vanness GR, Thomas AR, Bialek SR, Desai MM, Sofair AN.

J Clin Gastroenterol. 2010 Feb;44(2):e40-5. doi: 10.1097/MCG.0b013e3181b766ed.

17.

The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance.

Sofair AN, Barry V, Manos MM, Thomas A, Zaman A, Terrault NA, Murphy RC, Stabach N, Huie S, Van Ness G, Bell BP, Bialek S.

J Clin Gastroenterol. 2010 Apr;44(4):301-7. doi: 10.1097/MCG.0b013e3181b3f760.

PMID:
19745759
18.

Trends in hepatitis C virus infection among patients in the HIV Outpatient Study, 1996-2007.

Spradling PR, Richardson JT, Buchacz K, Moorman AC, Finelli L, Bell BP, Brooks JT; HIV Outpatient Study Investigators.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):388-96. doi: 10.1097/QAI.0b013e3181b67527.

PMID:
19738485
19.

Reduction in hepatitis B virus seroprevalence among U.S.-born children of foreign-born Asian parents -- benefit of universal infant hepatitis B vaccination.

Shuler CM, Fiore AE, Neeman R, Bell BP, Kuhnert W, Watkins S, Kilgour K, Arnold KE.

Vaccine. 2009 Oct 9;27(43):5942-7. doi: 10.1016/j.vaccine.2009.07.087. Epub 2009 Aug 11.

PMID:
19679217
20.

Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults.

Hammitt LL, Bulkow L, Hennessy TW, Zanis C, Snowball M, Williams JL, Bell BP, McMahon BJ.

J Infect Dis. 2008 Dec 15;198(12):1776-82. doi: 10.1086/593335.

PMID:
18976095
21.

Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.

Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP.

Pediatr Infect Dis J. 2008 Oct;27(10):881-5. doi: 10.1097/INF.0b013e31817702ba.

PMID:
18756185
22.

The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance.

Bell BP, Manos MM, Zaman A, Terrault N, Thomas A, Navarro VJ, Dhotre KB, Murphy RC, Van Ness GR, Stabach N, Robert ME, Bower WA, Bialek SR, Sofair AN.

Am J Gastroenterol. 2008 Nov;103(11):2727-36; quiz 2737. doi: 10.1111/j.1572-0241.2008.02071.x. Epub 2008 Jul 31.

PMID:
18684170
23.

Chronic liver disease among two American Indian patient populations in the southwestern United States, 2000-2003.

Bialek SR, Redd JT, Lynch A, Vogt T, Lewis S, Wilson C, Bell BP.

J Clin Gastroenterol. 2008 Aug;42(7):949-54.

PMID:
18668704
24.

National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.

Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP.

Prev Chronic Dis. 2008 Jul;5(3):A74. Epub 2008 Jun 15.

25.

Monitoring the impact of vaccines postlicensure: new challenges, new opportunities.

Schuchat A, Bell BP.

Expert Rev Vaccines. 2008 May;7(4):437-56. doi: 10.1586/14760584.7.4.437. Review.

PMID:
18444891
26.

Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.

Vogt TM, Wise ME, Bell BP, Finelli L.

J Infect Dis. 2008 May 1;197(9):1282-8. doi: 10.1086/586899.

PMID:
18422440
27.

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F.

Hepatology. 2008 Apr;47(4):1128-35. doi: 10.1002/hep.22165.

PMID:
18318441
28.

Limitations of conventionally derived chronic liver disease mortality rates: Results of a comprehensive assessment.

Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP.

Hepatology. 2008 Apr;47(4):1150-7. doi: 10.1002/hep.22181.

PMID:
18264998
29.

Hepatitis A vaccine versus immune globulin for postexposure prophylaxis.

Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP.

N Engl J Med. 2007 Oct 25;357(17):1685-94. Epub 2007 Oct 18.

30.

Hepatitis A 2004 vaccination in children: methods and findings of a survey in two states.

Fiore A, Baxter LC, Bell BP, Hershow R, Passaro D, Twiddy S, Baxter R, Levy PS.

Am J Prev Med. 2007 Oct;33(4):346-52.

PMID:
17888861
31.

Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000.

Thomas AR, Zaman A, Bell BP.

J Clin Gastroenterol. 2007 Oct;41(9):859-62.

PMID:
17881933
32.

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP.

Pediatrics. 2007 Aug;120(2):e373-81. Epub 2007 Jul 16.

PMID:
17636112
33.

Population-based surveillance for acute liver failure.

Bower WA, Johns M, Margolis HS, Williams IT, Bell BP.

Am J Gastroenterol. 2007 Nov;102(11):2459-63. Epub 2007 Jun 29. Erratum in: Am J Gastroenterol. 2008 Jan;103(1):255.

PMID:
17608778
34.

Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003.

Simard EP, Miller JT, George PA, Wasley A, Alter MJ, Bell BP, Finelli L.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):783-90. Epub 2007 May 24.

PMID:
17564979
35.

Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.

Bell BP, Negus S, Fiore AE, Plotnik J, Dhotre KB, Williams J, Shapiro CN, McMahon BJ.

Pediatr Infect Dis J. 2007 Feb;26(2):116-22.

PMID:
17259872
36.

The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.

Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP.

Pediatrics. 2007 Jan;119(1):e22-9.

PMID:
17200247
37.

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.

Pediatrics. 2007 Jan;119(1):e12-21.

PMID:
17200237
38.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2006 Dec 8;55(RR-16):1-33; quiz CE1-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Oct 26;56(42):1114.

39.

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP.

J Hepatol. 2006 Oct;45(4):529-38. Epub 2006 Jun 23.

PMID:
16879891
40.

Hepatitis A in the era of vaccination.

Wasley A, Fiore A, Bell BP.

Epidemiol Rev. 2006;28:101-11. Epub 2006 Jun 14. Review.

PMID:
16775039
41.

Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy.

Bower WA, Culver DH, Castor D, Wu Y, James VN, Zheng H, Hammer S, Kuhnert WL, Williams IT, Bell BP, Vlahov D, Dezzutti CS.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):293-7.

PMID:
16763522
42.

Hepatitis B virus infection: epidemiology and vaccination.

Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP.

Epidemiol Rev. 2006;28:112-25. Epub 2006 Jun 5. Review.

PMID:
16754644
43.

Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Advisory Committee on Immunization Practices (ACIP), Fiore AE, Wasley A, Bell BP.

MMWR Recomm Rep. 2006 May 19;55(RR-7):1-23.

44.

Locally acquired hepatitis E virus infection, El Paso, Texas.

Amon JJ, Drobeniuc J, Bower WA, MagaƱa JC, Escobedo MA, Williams IT, Bell BP, Armstrong GL.

J Med Virol. 2006 Jun;78(6):741-6.

PMID:
16628579
45.

What's next for the hepatitis A vaccine?

Rein DB, Fiore AE, Bell BP.

Lancet. 2006 Feb 18;367(9510):546-8. No abstract available.

PMID:
16488780
46.

Factors associated with hepatitis a vaccination among children 24 to 35 months of age: United States, 2003.

Amon JJ, Darling N, Fiore AE, Bell BP, Barker LE.

Pediatrics. 2006 Jan;117(1):30-3.

PMID:
16396857
47.

A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.

Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2005 Dec 23;54(RR-16):1-31. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Feb 17;55(6):158-9. MMWR Morb Mortal Wkly Rep. 2007 Dec 7;56(48):1267.

48.

Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies.

Victor JC, Surdina TY, Suleimenova SZ, Favorov MO, Bell BP, Monto AS.

Am J Epidemiol. 2006 Feb 1;163(3):204-10. Epub 2005 Dec 7.

PMID:
16339053
49.

Hepatitis A virus infection in the United States: serologic results from the Third National Health and Nutrition Examination Survey.

Bell BP, Kruszon-Moran D, Shapiro CN, Lambert SB, McQuillan GM, Margolis HS.

Vaccine. 2005 Dec 30;23(50):5798-806.

PMID:
16307834
50.

Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor.

Tugwell BD, Patel PR, Williams IT, Hedberg K, Chai F, Nainan OV, Thomas AR, Woll JE, Bell BP, Cieslak PR.

Ann Intern Med. 2005 Nov 1;143(9):648-54.

PMID:
16263887

Supplemental Content

Support Center